PASADENA, Calif.--(BUSINESS WIRE)--
Jacobs
Engineering Group Inc. (NYSE:JEC) announced today it was awarded a
contract to lead design and provide engineering services, procurement
and construction support for Pfizer,
Inc.’s new $350 million Global Biotechnology Center investment in
the Hangzhou Economic Development Area in China.
Under the terms of the agreement, Jacobs is responsible for developing
the overall site design, which includes aseptic fill/finish, drug
substance and central utility buildings; a quality laboratory;
administration offices; and a warehouse. The facility is being built to
produce monoclonal antibodies and also serve as a process development
and clinical supply site for biologic medicines in China.
In making the announcement, Jacobs Senior Vice President Life Sciences
Robert Norfleet stated, “This is an exciting opportunity for our Life
Sciences business. We have a long history of helping Pfizer grow and
expand its global manufacturing capabilities. We look forward to
partnering with Pfizer once again to develop this state-of-the-art
biotechnology center in China.”
The facility is expected to be complete in 2018.
Jacobs is one of the world’s largest and most diverse providers of
full-spectrum technical, professional and construction services for
industrial, commercial and government organizations globally. The
company employs 50,000 people and operates in more than 30 countries
around the world. Jacobs’ Life Sciences business is the largest
professional services provider to the pharmaceutical and biotechnology
industries. For more information, visit www.jacobs.com.
Statements made in this release that are not based on historical fact
are forward-looking statements. We base these forward-looking statements
on management’s current estimates and expectations as well as currently
available competitive, financial and economic data. Forward-looking
statements, however, are inherently uncertain. There are a variety of
factors that could cause business results to differ materially from our
forward-looking statements. For a description of some of the factors
which may occur that could cause actual results to differ from our
forward-looking statements please refer to our 2015 Form 10-K, and in
particular the discussions contained under Items 1 - Business, 1A - Risk
Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and
Analysis of Financial Condition and Results of Operations. We do not
undertake to update any forward-looking statements made herein.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160823005110/en/
Source: Jacobs Engineering Group Inc.